Cargando…
Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength
The pathophysiology of osteoporosis and sarcopenia. [Image: see text]
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078089/ https://www.ncbi.nlm.nih.gov/pubmed/31633306 http://dx.doi.org/10.1111/jdi.13165 |
_version_ | 1783507542116139008 |
---|---|
author | Hwang, Jawl‐Shan Lien, Angela Shin‐Yu Jiang, Yi‐Der |
author_facet | Hwang, Jawl‐Shan Lien, Angela Shin‐Yu Jiang, Yi‐Der |
author_sort | Hwang, Jawl‐Shan |
collection | PubMed |
description | The pathophysiology of osteoporosis and sarcopenia. [Image: see text] |
format | Online Article Text |
id | pubmed-7078089 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70780892020-03-19 Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength Hwang, Jawl‐Shan Lien, Angela Shin‐Yu Jiang, Yi‐Der J Diabetes Investig Commentaries The pathophysiology of osteoporosis and sarcopenia. [Image: see text] John Wiley and Sons Inc. 2019-11-26 2020-03 /pmc/articles/PMC7078089/ /pubmed/31633306 http://dx.doi.org/10.1111/jdi.13165 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Commentaries Hwang, Jawl‐Shan Lien, Angela Shin‐Yu Jiang, Yi‐Der Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength |
title | Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength |
title_full | Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength |
title_fullStr | Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength |
title_full_unstemmed | Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength |
title_short | Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength |
title_sort | commentary on the effects of receptor activator of nuclear factor‐b ligand inhibition on bone mass and muscle strength |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078089/ https://www.ncbi.nlm.nih.gov/pubmed/31633306 http://dx.doi.org/10.1111/jdi.13165 |
work_keys_str_mv | AT hwangjawlshan commentaryontheeffectsofreceptoractivatorofnuclearfactorbligandinhibitiononbonemassandmusclestrength AT lienangelashinyu commentaryontheeffectsofreceptoractivatorofnuclearfactorbligandinhibitiononbonemassandmusclestrength AT jiangyider commentaryontheeffectsofreceptoractivatorofnuclearfactorbligandinhibitiononbonemassandmusclestrength |